1991
DOI: 10.1111/j.1365-2125.1991.tb03933.x
|View full text |Cite
|
Sign up to set email alerts
|

The bioavailability of sustained release nicotinic acid formulations.

Abstract: 1. The bioavailability of three nicotinic acid formulations was investigated in a randomized cross‐over study. 2. Single doses of nicotinic acid (500 mg) were given to seven healthy volunteers. The concentrations of nicotinic acid and its main metabolite nicotinuric acid were measured in serum up to 8 h and in urine up to 24 h. 3. The relative bioavailability of unchanged nicotinic acid from two slow release formulations compared with a rapid‐release form was only 1% and 25%, respectively. Relative values of A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2003
2003
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 13 publications
0
10
0
Order By: Relevance
“…NA has a relative bioavailability of up to 25%, whereas 15-30% of the absorbed vitamin bounds to plasma proteins. NA has an extensive hepatic metabolism, which is also associated with the hepatic toxicity caused by higher doses of NA [45][46][47]. Buccal delivery of APIs has the main advantage of bypassing the first pass effect, including the avoidance of presystemic elimination within the GI tract.…”
Section: Discussionmentioning
confidence: 99%
“…NA has a relative bioavailability of up to 25%, whereas 15-30% of the absorbed vitamin bounds to plasma proteins. NA has an extensive hepatic metabolism, which is also associated with the hepatic toxicity caused by higher doses of NA [45][46][47]. Buccal delivery of APIs has the main advantage of bypassing the first pass effect, including the avoidance of presystemic elimination within the GI tract.…”
Section: Discussionmentioning
confidence: 99%
“…[6][7][8] The rate and extent of the metabolite formation via the glycine conjugation pathway (pathway 1, NUA) following niacin administration have been shown to depend on the rate of niacin release from the niacin formulations following single-dose administrations of 500 mg niacin. 18,19 However, the effect of rate on the NAM metabolic pathway (pathway 2) or at therapeutic doses of 2000 mg has not been characterized. The objective of this study was to characterize the single-dose pharmacokinetics of 2000 mg niacin in solution delivered orally at different input rates.…”
Section: Discussionmentioning
confidence: 99%
“…Immediate‐release niacin is associated with cutaneous flushing, whereas sustained‐release formulations have been associated with hepatotoxicity 6 – 8 . The rate and extent of the metabolite formation via the glycine conjugation pathway (pathway 1, NUA) following niacin administration have been shown to depend on the rate of niacin release from the niacin formulations following single‐dose administrations of 500 mg niacin 18 , 19 . However, the effect of rate on the NAM metabolic pathway (pathway 2) or at therapeutic doses of 2000 mg has not been characterized.…”
Section: Discussionmentioning
confidence: 99%
“…There is evidence that the flushing symptoms occur while the concentration of nicotinic acid and nicotinuric acid in plasma is increasing, independently of the absolute concentration (Cayen 1985;Neuvonen et al 1991).…”
Section: Discussionmentioning
confidence: 97%